Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Genetic Associations and Epidemiology, and Antioxidant Activity and Oxidative Stress.
A molecular cell atlas of mouse lemur, an emerging model primate
Mouse lemur cell atlas informs primate genes, physiology and disease
Genome‐wide association studies of TDP‐43 proteinopathy and hippocampal sclerosis reveal shared genetic associations with APOE and TMEM106B
Neuropathologic lesions and comorbidity in Alzheimer disease and related dementias in a heterogeneous clinical population
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Sex differences in the genetic predictors of Alzheimer’s pathology
Primum non nocere: a call for balance when reporting on CTE
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease
Transethnic genome‐wide scan identifies novel Alzheimer's disease loci
Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies
Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings
Rho‐associated protein kinase 1 (<scp>ROCK</scp>1) is increased in Alzheimer's disease and <scp>ROCK</scp>1 depletion reduces amyloid‐β levels in brain
A novel Alzheimer disease locus located near the gene encoding tau protein
Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias
Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease
Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-β Production in an Alzheimer's Disease Mouse Model
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
Antioxidants for Alzheimer Disease
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease